Abstract: Methods, compositions and kits are disclosed directed at levetiracetam derivatives, immunogens, signal generating moieties, antibodies that bind levetiracetam and immunoassays for detection of levetiracetam.

Abstract: Compounds and methods for use in detecting gabapentin in a sample suspected of containing gabapentin are disclosed. Gabapentin derivatives are used to produce gabapentin conjugates. A gabapentin-immunogenic carrier conjugate may be used as an immunogen for the preparation of an anti-gabapentin antibody. A gabapentin-detectable label may be used in a signal producing system in gabapentin assays.

Abstract: Methods, compositions and kits are disclosed directed at levetiracetam derivatives, immunogens, signal generating moieties, antibodies that bind levetiracetam and immunoassays for detection of levetiracetam.

Abstract: Compounds and methods for use in detecting gabapentin in a sample suspected of containing gabapentin are disclosed. Gabapentin derivatives are used to produce gabapentin conjugates. A gabapentin-immunogenic carrier conjugate may be used as an immunogen for the preparation of an anti-gabapentin antibody. A gabapentin-detectable label may be used in a signal producing system in gabapentin assays.

Abstract: A system to light a cavity 19 in an appliance. A source or light emitter 27 is mounted on a circuit board 32, so that the light emanating from said source or light emitter 27, is concentrated into a light beam using an optical collimator system 28 or in some cases a Fresnel arrangement; wherein the foregoing elements may be found outside a door 14, which allow access into the cavity; thus the light beam exiting the optical collimator 27 or Fresnel arrangement travels a distance though air between the optical collimator system 27 or Fresnel arrangement and the upper face of the light guide 29 which is placed on the door 14, the light guide 29 transports the luminous flux towards a notch which diverts said luminous flux directing into the cavity's 19 interior.

Abstract: Methods, compositions and kits are disclosed directed at levetiracetam derivatives, immunogens, signal generating moieties, antibodies that bind levetiracetam and immunoassays for detection of levetiracetam.

Abstract: Methods, compositions and kits are disclosed directed at levetiracetam derivatives, immunogens, signal generating moieties, antibodies that bind levetiracetam and immunoassays for detection of levetiracetam.

Abstract: A system to light a cavity 19 in an appliance. A source or light emitter 27 is mounted on a circuit board 32, so that the light emanating from said source or light emitter 27, is concentrated into a light beam using an optical collimator system 28 or in some cases a Fresnel arrangement; wherein the foregoing elements may be found outside a door 14, which allow access into the cavity; thus the light beam exiting the optical collimator 27 or Fresnel arrangement travels a distance though air between the optical collimator system 27 or Fresnel arrangement and the upper face of the light guide 29 which is placed on the door 14, the light guide 29 transports the luminous flux towards a notch which diverts said luminous flux directing into the cavity's 19 interior.

Abstract: Methods, compositions and kits are disclosed directed at levetiracetam derivatives, immunogens, signal generating moieties, antibodies that bind levetiracetam and immunoassays for detection of levetiracetam.

Abstract: Diacetonefructose derivatives have substituents at the hydroxyl-position. Diacetonefructose derivatives may include immunogenic moieties to prepare anti-diacetonefructose derivative antibodies, or antigenic moieties for immunodiagnostic assays. Also, the diacetonefructose derivatives can include signal generating moieties for detecting the presence or amount of the diacetonefructose derivative in a sample. Additionally, the diacetonefructose derivatives can be used in immunodiagnostic assays to compete with topiramate for binding with anti-diacetonefructose derivative antibodies. Also, methods, compositions and kits are disclosed directed at diacetonefructose derivatives, immunogens, signal generating moieties and immunoassays for topiramate.

Abstract: Compounds and methods for use in detecting gabapentin in a sample suspected of containing gabapentin are disclosed. Gabapentin derivatives are used to produce gabapentin conjugates. A gabapentin-immunogenic carrier conjugate may be used as an immunogen for the preparation of an anti-gabapentin antibody. A gabapentin-detectable label may be used in a signal producing system in gabapentin assays.